Omnicell Inc. Stock
Omnicell Inc. Stock
With 3 Buy predictions and 2 Sell predictions the community is currently undecided on Omnicell Inc..
With a target price of 35 € there is a positive potential of 38.89% for Omnicell Inc. compared to the current price of 25.2 €.
Pros and Cons of Omnicell Inc. in the next few years
Pros
?
B****
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Omnicell Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Omnicell Inc. | - | -1.563% | 0.000% | -52.453% | -28.000% | -78.824% | -65.299% |
Integer Hldg | -2.880% | 0.000% | -5.607% | 38.356% | 13.483% | 30.323% | 59.130% |
Healthequity Inc. | - | 0.000% | -2.649% | 57.051% | 23.529% | 17.150% | - |
Bruker Corp. | 1.220% | -13.961% | -22.505% | -10.849% | -2.135% | - | - |
Comments
Omnicell, Inc. (NASDAQ: OMCL) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $38.00 price target on the stock.
Show more
Ratings data for OMCL provided by MarketBeat
Omnicell, Inc. (NASDAQ: OMCL) had its price target lowered by analysts at Benchmark Co. from $42.00 to $38.00. They now have a "buy" rating on the stock.
Show more
Ratings data for OMCL provided by MarketBeat
Omnicell, Inc. (NASDAQ: OMCL) is now covered by analysts at Barclays PLC. They set an "underweight" rating and a $33.00 price target on the stock.
Show more
Ratings data for OMCL provided by MarketBeat